BR112015032033A2 - Composição de imunoterapia e uso da mesma - Google Patents

Composição de imunoterapia e uso da mesma

Info

Publication number
BR112015032033A2
BR112015032033A2 BR112015032033A BR112015032033A BR112015032033A2 BR 112015032033 A2 BR112015032033 A2 BR 112015032033A2 BR 112015032033 A BR112015032033 A BR 112015032033A BR 112015032033 A BR112015032033 A BR 112015032033A BR 112015032033 A2 BR112015032033 A2 BR 112015032033A2
Authority
BR
Brazil
Prior art keywords
preventing
immunotherapy composition
inactivated
severity
incidence
Prior art date
Application number
BR112015032033A
Other languages
English (en)
Inventor
Benghezal Mohammed
Marshall Barry
Fulurija Alma
Walton Senta
Original Assignee
Ondek Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013902268A external-priority patent/AU2013902268A0/en
Application filed by Ondek Pty Ltd filed Critical Ondek Pty Ltd
Publication of BR112015032033A2 publication Critical patent/BR112015032033A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Dermatology (AREA)
  • Pediatric Medicine (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Dairy Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

COMPOSIÇÃO DE IMUNOTERAPIA E USO DE UMA CÉLULA DE H. PYLORI INATIVADA E/OU MORTA OU UM LISADO CELULAR DA MESMA E UM VEÍCULO FARMACEUTICAMENTE ACEITÁVEL. A presente invenção se refere ao campo da prevenção ou redução da incidência ou da gravidade de uma resposta imunitária alérgica, e composições para prevenir ou reduzir a incidência ou a gravidade de uma resposta imunitária alérgica. Por exemplo, a presente invenção proporciona composições que compreendem células inativadas e/ou mortas de Helicobacter pylori ou um lisado celular das mesmas, e métodos e/ou seus usos para atrasar ou prevenir ou interromper ou abrandar o aparecimento de uma ou mais condições alérgicas em um sujeito.
BR112015032033A 2013-06-21 2014-06-20 Composição de imunoterapia e uso da mesma BR112015032033A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2013902268A AU2013902268A0 (en) 2013-06-21 Immunotherapy composition (ii) and use thereof
AU2013902262A AU2013902262A0 (en) 2013-06-21 Immunotherapy composition (i) and use thereof
AU2013903925A AU2013903925A0 (en) 2013-10-11 Immunotherapy composition (III) and use thereof
AU2013905007A AU2013905007A0 (en) 2013-12-20 Immunotherapy composition (II) and use thereof
PCT/AU2014/050087 WO2014201525A1 (en) 2013-06-21 2014-06-20 Immunotherapy composition and use thereof

Publications (1)

Publication Number Publication Date
BR112015032033A2 true BR112015032033A2 (pt) 2017-08-29

Family

ID=52103716

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015032033A BR112015032033A2 (pt) 2013-06-21 2014-06-20 Composição de imunoterapia e uso da mesma

Country Status (9)

Country Link
US (2) US9555104B2 (pt)
EP (1) EP3010517A4 (pt)
JP (2) JP6495256B2 (pt)
CN (1) CN105636601A (pt)
AU (1) AU2014284047B2 (pt)
BR (1) BR112015032033A2 (pt)
CA (1) CA2915673C (pt)
SG (1) SG11201510150VA (pt)
WO (1) WO2014201525A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014284047B2 (en) 2013-06-21 2018-11-22 Ondek Pty Ltd Immunotherapy composition and use thereof
EP3538558A4 (en) 2016-11-09 2020-07-15 North Carolina State University TREATMENT OF ALLERGIC DISEASES WITH A CHIMERAL PROTEIN
US20210009678A1 (en) * 2018-03-23 2021-01-14 North Carolina State University Methods and compositions for allergic disorders
WO2021216598A1 (en) * 2020-04-22 2021-10-28 Yobee Care, Inc. Methods and compositions for preventing atopic march and treating skin conditions
TWI802009B (zh) * 2021-09-16 2023-05-11 創百股份有限公司 使用熱致死的乳酸菌菌株來治療和/或預防微粒物質-誘發的肺損傷
WO2023074607A1 (ja) * 2021-10-25 2023-05-04 インテグリカルチャー株式会社 細胞保持材、センサー、枠部材および細胞保持方法
CN114292896B (zh) * 2021-12-24 2023-08-22 四川大学华西医院 一种幽门螺杆菌药敏检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008509168A (ja) * 2004-08-13 2008-03-27 マーシャル，バリー，ジェー． 細菌デリバリシステム
ATE516817T1 (de) * 2005-06-16 2011-08-15 Univ Gent Impfstoffe zur immunisierung gegen helicobacter
CN102176907A (zh) * 2008-10-08 2011-09-07 免疫解决方案有限公司 用于产生粘膜免疫的口服疫苗
BRPI1100857A2 (pt) 2011-03-18 2013-05-21 Alexandre Eduardo Nowill agente imunomodulador e suas combinaÇÕes, seu uso e mÉtodo imunoterÁpico para a recontextualizaÇço, reprogramaÇço e reconduÇço do sistema imune em tempo real
JP2013116089A (ja) * 2011-12-05 2013-06-13 Nagoya Seiraku Kk 抗ヘリコバクター・ピロリ効果を有する乳酸菌株、その乳酸菌株を含む抗ヘリコバクター・ピロリ剤、及びその乳酸菌株を含む飲食品
CN105392780A (zh) 2013-05-24 2016-03-09 雀巢产品技术援助有限公司 用于预测肠易激综合征诊断的途径特异性测定
AU2014284047B2 (en) 2013-06-21 2018-11-22 Ondek Pty Ltd Immunotherapy composition and use thereof

Also Published As

Publication number Publication date
CA2915673A1 (en) 2014-12-24
US10130704B2 (en) 2018-11-20
US20170165357A1 (en) 2017-06-15
CA2915673C (en) 2021-10-12
EP3010517A4 (en) 2017-04-26
CN105636601A (zh) 2016-06-01
SG11201510150VA (en) 2016-01-28
EP3010517A1 (en) 2016-04-27
US9555104B2 (en) 2017-01-31
JP2019059770A (ja) 2019-04-18
US20160175429A1 (en) 2016-06-23
JP6495256B2 (ja) 2019-04-03
AU2014284047A1 (en) 2016-02-04
AU2014284047B2 (en) 2018-11-22
WO2014201525A1 (en) 2014-12-24
JP2016522222A (ja) 2016-07-28

Similar Documents

Publication Publication Date Title
BR112015032033A2 (pt) Composição de imunoterapia e uso da mesma
BR112018077266A2 (pt) composições compreendendo cepas bacterianas
EP3698574A4 (en) PROCEDURES AND DEVICES FOR 5G TO 2G / 3G FALLBACK WITHOUT ACCESS TO AN LTE AIR INTERFACE
CR20150465A (es) Virus de la enfermedad de newcastle y usos de los mismos
CO7141405A2 (es) Uso de pro-fungicidas de uk-2a para el control de la sigatoka negra
BR112016014271A2 (pt) composições tópicas em gel incluindo polímero de poli(monoestearoil glicerol-co-succi¬nato) e métodos para aprimorar a aplicação tópica de um agente de benefício
BR112017002761A2 (pt) composições anti-metanogênicas e usos das mesmas
UY35298A (es) Formulación en dispersión sólida de un compuesto antiviral
EA201990032A1 (ru) Способы и композиции для терапии посредством потенциирования стволовых клеток
BR112016007128A2 (pt) concessão de permissões para um objeto quando adicionando pessoas a uma conversação
PH12016500793B1 (en) Soft pastilles containing turmeric extracts
BR112016012489A2 (pt) cápsula, método de preparação de uma cápsula contendo flavonoides totais de desmodium styracifolium, e uso da cápsula
BR112016022463A2 (pt) método para induzir uma resposta imune em um indivíduo, primeira e segunda composições imunogênicas, e, uso de uma primeira composição imunogênica e de uma segunda composição imunogênica
BR112017010804A2 (pt) polímero em multi-estágio, sua composição, seu método de preparação, seu uso e composição compreendendo o mesmo
BR112021024793A2 (pt) Composições compreendendo iga secretora e probióticos
BR112016005509A8 (pt) método de preparação de um extrato de sementes de urucum (anato), composição, extrato vegetal, e composição farmacêutica
BR112017011170A2 (pt) método para determinar a citotoxicidade dependente do complemento de uma composição
WO2016141320A3 (en) Non-neuroinvasive viruses and uses thereof
CR20160369A (es) Composiciones para uso en el tratamiento de afecciones alérgicas
MX2018014977A (es) Composiciones y metodos para formulaciones de alfavirus vivos atenuados.
AU2017241669A1 (en) Live, attenuated alphavirus constructs and methods and uses thereof
BR112014023092A8 (pt) Composição imunogênica, método para a prevenção de infecção ou doença por hpv em um indivíduo, e, kit
WO2014167582A3 (en) Vaccine composition for prophylaxis in ruminants
EP3677258A4 (en) USES OF CANNABIDIOL IN THE MANUFACTURING OF MEDICINAL PRODUCTS FOR RESISTANCE TO INFLUENZA
EP4233915A3 (en) Modified release formulations of viloxazine

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements